• Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the resistance syndrome (syndrome X). Diabetes 1992;41:715-22
• Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595- 1607
• Kaplan NM. The deadly quartet: upperbody obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20
• Yudkin JS. Relationship of serum C3 complement with insulin resistance and coronary heart disease-cause, consequence or common antecedent? Eur Heart J 2000;21:1036-9
• Tonstad S, Hjermann I. A high risk score for coronary heart disease is associated with the metabolic syndrome in 40-yearold men and women. J Cardiovasc Risk 2003;10:129-135
• Welch GN, Loscalzo J. Homocysteine and atherotrombosis. N Engl J Med 1998;338: 1042-50
• Hoogeveen EK, Kostense PJ, Beks PJ, et al. Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol 1998;18:133-8
• Hoogeveen EK, Kostense PJ, Jakobs C, et al. Hyperhomocysteinemia increase risk of death, especially in type 2 diabetes: 5 year follow-up of the Hoorn Study. Circulation 2000;101:1506-11
• Boushey CJ, Beresford SA, Omenn GS, et al. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049- 57
• Eikelboom JW, Lonn E, Genest JJr, et al. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999;131:363-75
• Araki A, Sako Y, Ito H. Plasma homocysteine concentrations in Japanese patients with non-insulin dependent diabetes mellitus: effect of methyl cobalamin treatment. Atherosclerosis 1993;103:149-57
• Munshi MN, Stone A, Fink L, et al. Hyperhomocysteinemia following a methionine load in patients with noninsulin-dependent diabetes mellitus and macrovascular disease. Metabolism 1996;45:133-5
• Fonseca VA, Mudaliar S, Schmidt B, et al. Plasma homocysteine concentrations are regulated by acute hyperinsulinaemia in nondiabetic but not type 2 diabetic subjects. Metabolism 1998;47:686-9
• Zinneman HH, Nuttall FQ, Goetz FC. Effect of endogenous insulin on human amino acid metabolism. Diabetes 1966;15:5-8
• Expert Panel on Detection, evaluation, and treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285: 2486-97
• Sebastio G, Sperandeo MP, Panico M, et al. The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet 1995;56:1324-33
• Selhub J. Homocysteine metabolism. Annu Rev Nutr 1999;19:217-46
• Mudd SH, Skovby F, Levy HL, et al. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1985;37:1-31
• Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997;96:2542-4
• Tawakol A, Omland T, Gerhard M, et al. Hyperhomocyst(e)inemia: is associated with impaired endothelial-dependent vasodilatation in humans. Circulation 1997;95:1119-21
• Majors A, Ehrhart LA, Pezacka EH. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol 1997;17:2074-81
• Al-Obaidi MK, Philippou H, Stubs PJ, et al. Relationship between homocysteine, Factor VIIa, and thrombin generation in acute coronary syndromes. Circulation 2000;101:372-7
• Malinow MR. Homocst(e)ine and arterial occlusive diseases. J Intern Med 1994;236:603-17
• Stamler JS, Slivka A. Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr Rev 1996;54:1-30
• Kahleova R, Palyzova D, Zvara K, et al. Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. Am J Hypertens 2002;15:857- 64
• Jermendy G, Hidvegi T, Hetyesi K. Plasma homocysteine levels in hyperinsulinemic patients. Orv Hetil 2001;142:277-81
• Jacobsen DW. Homocysteine and vitamins in cardiovascular disease. Clinical Chemistry 1998;44:1833-43
• Meigs JB, Jacques PF, Selhub J, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24:1403-10
• Godsland IF, Rosankiewicz JR, Proudler AJ, et al. Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men. J Clin Endocrinol Metab 2001;86:719-23
• Valentine RJ, Kaplan HS, Green R, et al. Lipoprotein (a), homocysteine, and hypercoagulable states in young men with premature peripheral atherosclerosis: a prospective, controlled analysis. J Vasc Surg 1996;23:53-61

Vancouver

Güven A, İnanç F. Plasma Homocysteine and Lipoprotein (A) Levels in Patients with Metabolic Syndrome. EUR J GEN MED. 2004;1(2):38-42. https://doi.org/10.29333/ejgm/82182

APA

Güven, A., & İnanç, F. (2004). Plasma Homocysteine and Lipoprotein (A) Levels in Patients with Metabolic Syndrome. European Journal of General Medicine, 1(2), 38-42. https://doi.org/10.29333/ejgm/82182

AMA

Güven A, İnanç F. Plasma Homocysteine and Lipoprotein (A) Levels in Patients with Metabolic Syndrome. EUR J GEN MED. 2004;1(2), 38-42. https://doi.org/10.29333/ejgm/82182

Chicago

Güven, Aytekin, and Fatma İnanç. "Plasma Homocysteine and Lipoprotein (A) Levels in Patients with Metabolic Syndrome". European Journal of General Medicine 2004 1 no. 2 (2004): 38-42. https://doi.org/10.29333/ejgm/82182

Harvard

Güven, A., and İnanç, F. (2004). Plasma Homocysteine and Lipoprotein (A) Levels in Patients with Metabolic Syndrome. European Journal of General Medicine, 1(2), pp. 38-42. https://doi.org/10.29333/ejgm/82182

MLA

Güven, Aytekin et al. "Plasma Homocysteine and Lipoprotein (A) Levels in Patients with Metabolic Syndrome". European Journal of General Medicine, vol. 1, no. 2, 2004, pp. 38-42. https://doi.org/10.29333/ejgm/82182